---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-040275"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2024-10-07T23:59:59+00:00"
generated_at: "2026-05-30T19:40:05.621397+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Sanara MedTech appoints former LHC Group CEO Keith Myers to board; James Stuckert resigns as director

## Summary
- James W. Stuckert resigned as director effective Oct 4, 2024; will remain as Director Emeritus in non-voting advisory capacity.
- Keith Myers appointed to board; he co-founded LHC Group and served as chairman/CEO until LHC's merger with Optum in 2023.
- Myers will serve on Corporate Development Committee; receives $90k annual board retainer and $5k committee fee under standard policy.
- Stuckert's resignation was not due to any disagreement with the company's operations, policies, or practices.

## SEC filing metadata
- accession: 0001493152-24-040275
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2024-10-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315224040275/0001493152-24-040275-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315224040275/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-040275
- JSON: https://secwatch.observer/filing/0001493152-24-040275.json
- Plain text: https://secwatch.observer/filing/0001493152-24-040275.txt

## Key facts
- Executive change
  James W. Stuckert resigned as Director at Sanara MedTech Inc..
  - Action: resigned
  - Role: Director
  source text: On October 4, 2024, James W. Stuckert notified Sanara MedTech Inc. (the “Company”) of his intention to resign from his position as a member of the Company’s Board of Directors (the “Board”) and each of its committees upon which he serves, effective as of October 4, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315224040275/0001493152-24-040275-index.htm
- Executive change
  Keith Myers was appointed as Director at Sanara MedTech Inc..
  - Action: appointed
  - Role: Director
  source text: On October 4, 2024, the Board appointed Keith Myers as a director of the Company, effective October 4, 2024 (the “Effective Date”), to fill the vacancy resulting from Mr. Stuckert’s resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315224040275/0001493152-24-040275-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.